Introduction {#Sec1}
============

A ureterovaginal fistula (UVF) is an abnormal channel between the ureter and vagina, which is a severely disabling complication resulting in incontinence, infection, and discomfort; it is often diagnosed postoperatively \[[@CR1]\]. The incidence of UVF has been increasing due to the growing use of the laparoscopic surgical technique \[[@CR2]\]. Traditionally, a laparotomy or laparoscopic surgery has been used to repair the delayed UVF \[[@CR3], [@CR4]\]; however, the serious local inflammatory response has slowed surgical repair. In recent years, minimally invasive treatment has been widely used for this disease. We have retrospectively analyzed 46 patients who were treated with minimally invasive treatment of UVF at our hospital from 2006 to 2016. In this review, we discuss the treatments to repair UVF, the required techniques, and postoperative recommendations.

Patients and methods {#Sec2}
====================

The mean age of selected patients suffering from ureterovaginal fistula was 42.5 years (range, 34--53). They all had unilateral ureteric injury (27 left and 19 right). All patients who were followed had delayed UVF after laparoscopic total hysterectomy (56.5%), laparoscopic radical resection of cervical cancer (34.8%), and laparotomy cervical cancer resection procedures (8.6%). The injuries were diagnosed in a median 3.7 days (range, 24 h to 42 days) after the primary procedure, when they were typically discovered having a urine leak from the vagina. The lesion-side ureters of these patients were opened; in the retroperitoneum, extravasation of contrast medium from the computed tomography urogram (CTU) of the distal ureter was revealed. The CTU revealed 35 patients with delayed kidney development lateral to the injuries. In the other 11 patients, renal imaging was normal. Ultrasound showed all of them to have hydronephrosis---19 mild and 27 moderate. A routine chemistry examination of the vaginal leakage revealed that urea and creatinine levels were close to normal urine. Flexible cystoscopy showed that the bladder mucosa was normal and that there was no blue-tinged urine extravasation in the vagina after injecting indigo carmine or methylene blue in the bladder to help rule out vesicovaginal fistula.

Treatment {#Sec3}
---------

### Ureteroscopy {#Sec4}

Under continuous epidural or general anesthesia, all 46 patients were placed in the flank-reclining, split-leg position for simultaneous antegrade and retrograde ureteroscopy. We inserted an F16 ureteroscope in the bladder through the urethra. First, we made a ureteroscopic observation to again rule out vesicovaginal fistula. Then, a Zebra urological guide wire, carrying a ureteral scope, was inserted in the injured side of the ureter as far as the injury site. A Holmium laser was used when the cavity was too narrow or the surgery suture was met. Forty-six patients having a definitive diagnosis of delayed UVF were classified according to the lesion's description, as follows:Class 1: The ureteric injuries were only fistulas, the ureteral mucosa was continuous, and the Zebra urological guide wire could be uplinked into the renal pelvis along the ureteral mucosa (34 cases).Class 2: More than half the diameter of the ureter was lacerated, a segment of the ureteral wall was a coloboma or collapsed, and the Zebra guide wire would not pass through the injury (9 cases).Class 3: The ureters were completely avulsed and the lacerated ends were filled in by the adjacent tissue (2 cases).Class 4: The injured ureter was completely atretic (1 case).

### Ureteric stent placement {#Sec5}

For Classes 1, two or three double-J (D-J) stents were indwelled over the injury through the Zebra guide wire, which uplinked into the renal pelvis along the ureter's mucous membrane. The stents were confirmed to be in their appropriate positions during the operation with ultrasonography.

### Endoscopic realignment for treatment \[[@CR5]\] {#Sec6}

The ureters of Class 2 were injured so seriously that the guide wire could hardly pass through the damaged region to reach the pelvis by retrograde ureteroscopy. Percutaneous nephroscopy had to be used to admit a flexible ureteroscope into the injury and insert the guide wire into the retroperitoneal space. A rigid ureteroscope was inserted retrogradely through the distal ureter to the injury. Then, a double ureteroscopic joint exploration and realignment was accomplished.

The guide wire was detected by the rigid ureteroscope, which was seized by the tip with an endoscopic grasping forceps and pulled out from urethra (using the foreign-body clamp in the ureteroscope to clip the guide wire outside the body through the diseased side of the distal ureter, bladder, and urethra), placing three D-J stents along the guide wire and over the fistula.

### Treatment of ureteral occlusion {#Sec7}

The ureters of Classes 3 and 4 were in complete occlusion, with the ureteroscope and guide wire unable to open the occluded portion. Therefore, a "cut-to-the-light" technique was employed \[[@CR6]\], with the ureteral segments being aligned via ultrasonographic and endoscopic control. The room light was dimmed and the rigid ureteroscope's light was turned off. Using the light source of the flexible ureteroscope that was inserted through the nephrostomy as a guide, we used the Holmium laser to restore ureteral continuity. A guide wire was indwelled across the area and uplinked to the renal pelvis, then three D-J stents were placed along the guide wire.

### Treatment of secondary ureteric stricture {#Sec8}

Ten patients had recurrent stenosis, which needed ureteroscopic endoureterotomy. First, we made an adequate longitudinal endoluminal incision of the strictured segment of the ureter and vaporized the scars until the periureteral fat was seen. Then, we indwelled three D-J stents for at least 6 weeks. We repeated the internal urethrectomy and replaced the stents after 6--12 months if the narrowing reappeared.

Results {#Sec9}
=======

Results of the surgical treatment are shown in Table [1](#Tab1){ref-type="table"} and Table [2](#Tab2){ref-type="table"}. Urine leakage decreased significantly and no obvious leakage became evident within 48 h postoperatively.Table 1Results listAge-bracket(y)SideExtent of injuryInitial operationTime of recognition(days)Operative time(min)Hospital time(days)Subsequent procedure140--45RClass 1a8303III235--40LClass 1b3403I340--45LClass 1b6403I440--45LClass 1a5355III535--40RClass 1b2303I645--50RClass 1a3305III740--45RClass 1c4354III840--45LClass 1b7304I&II940--45LClass 1b2303III1045--50RClass 1a1253I1140--45LClass 1a2254I1225--35LClass 1a5254I&II1335--40RClass 1a2354III1440--45LClass 1a3304I1550--55LClass 1a2405I&II1640--45LClass 1a2404I1745--50RClass 1b1603I1835--40LClass 1a2505III1940--45LClass 1b8503III2035--40LClass 1a1403III2140--45RClass 1a5404I2225--35RClass 1b6304I&II2350--55RClass 1a2303III2450--55RClass 1a4254III2540--45LClass 1b5304I2645--50LClass 1a10404III2750--55RClass 1b4404I2840--45LClass 1b6353III2940--45LClass 1b1305III3040--45RClass 1a3405III3125--35LClass 1a3354I3235--40LClass 1a3403I3335--40RClass 1b1403III3445--50RClass 1a5454I3525--35LClass 2a6809I&II3635--40LClass 2c37510I&II3745--50LClass 2a3707I3845--50RClass 2c42708IV3945--50LClass 2a2657I4045--50RClass 2c46010I&II4145--50RClass 2b4607I4240--45LClass 2a3907I4340--45LClass 2b8759I&II4445--50LClass 3b1906I4550--55RClass 3a1908I&II4640--45LClass 4a411010I&II*Abbreviation*: *a* Laparoscopic total hysterectomy, *b* Laparoscopic radical resection of cervical cancer, *c* Laparotomic cervical cancer resection procedures, *I* Replace D-J stents every 6--12 months, *II* Ureteroscopic endoureterotomy or re-expand with balloon every 6--12 months; *III* Removed the double-j stents after 3--6 months, *IV* Exchange nephrostomy tube every monthTable 2Statistical of ResultsSuccessful operationFailure operationTotalRemoved D-J stents post operationReplace D-J stents regularlyClass 11618034Class 20819Class 30202Class 40101Total162914645

For Class 1, of the 34 patients who successfully underwent retrograde ureteric stenting,16 had their stents removed after 3--6 months. The other 18 needed to have stent replacement or have their endoureterotomy re-expanded every 6--12 months. The mean operating time was 35 min (range, 25--60 min), and the mean hospital stay was 3.8 days (range, 3--5 days).

Eleven Class 2, 3, and 4 patients underwent realignment of rigid and flexible ureteroscopy for stenting, needing replacement of their D-J stents or reexpanded with incision every 6 months. The antegrade flexible ureteroscopy ensured that the stents formed in the correct position and that the nephrostomy drainage was placed. The nephrostomy tube was left in place for 1--2 weeks to decrease intravesicular pressure and minimize reflux through stents. The other Class 2 patient, whose injury was healed by scar tissue, was diagnosed 42 days after the initial operation. After the ureteroscope was withdrawn, the scar's "pseudo" tunnel narrowed again, requiring a repeat nephrostomy.She had to change the nephrostomy tube every month. The mean operating time was 80 ± 2 min (range, 60--110 min), and the mean hospital stay was 8.2 days (range, 6--10 days). To avoid sepsis and infection during hospitalization, the antibiotics should be used for 3 days routinely.

The catheter was indwelled in all 46 patients at the end of the operation and removed 2 weeks later. The overall catheterization success rate was 97.8%. There were no major complications, and blood loss was minimal. In the 6-month-to-3-year follow-ups (average, 18.6 months), ultrasound and intravenous pyelograms showed the ureter to be unobstructed, with the pelviureteric hydrocele significantly reduced or eradicated.

Discussion {#Sec10}
==========

Almost all UVFs are linked to an iatrogenic lesion, which usually follows pelvic and gynecological surgery \[[@CR7], [@CR8]\]. It occurs as one of the rare and serious surgical complications \[[@CR9]\]. The incidence of UVF can be attributed to the surgical technique \[[@CR10]\] and its technical difficulty \[[@CR11]\], although the risk factors for the underlying pathology of individual patients are not identical. Based on the surgical history, clinical symptoms, and auxiliary examination, diagnosis of UVF is not complicated \[[@CR12]\].

For economic reasons, many surgeons dislike taking a patient who has undergone previous ureteral surgery, so UVF patients are often difficult to diagnose intraoperatively \[[@CR13]\], with a median time to diagnosis of 3--30 days post injury. The basic tenet in treating a UVF is to restore the continuity of the urinary tract, protect kidney function, reduce localized stenosis, and avoid urinary fistula formation \[[@CR14]\].

Due to secondary renal damage resulting from ureter-repair surgery or reconstruction, preoperative excretory urography or other auxiliary methods are needed to determine contralateral renal function, which is of great value in deciding how to deal with the damaged ureter. Urologists should adopt a comprehensive protocol according to the type, position, and degree of injuries.

Although the success rate, operative complications, and long-term outcome of traditional early surgical treatment for UVF are similar to delayed operation \[[@CR15], [@CR16]\], we suggest that UVF repair surgery or ureteric reimplantation be completed in the early stages \[[@CR17], [@CR18]\], which might avoid renal damage and reduce patient's pain and financial burden. Generally, first-stage repair surgery should be available intraoperatively or within 24 h after ureteral injury. But for the delayed diagnosis cases and severe shockers with complicated injuries, repair surgery should be put off for 3--6 months after urine transfer \[[@CR19]\].

In recent years, retrograde ureteric stenting has been recommended for the first stage of UVF, which reduces urine leakage in internal drainage and in inflammatory lesions \[[@CR20]\]. UVF can typically be treated successfully by ureteric stenting as long as the ureter wall is continuous.

Generally speaking, there is no need to disconnect the ureter during transurethral ureteroscopy and retrograde stenting, UVF can typically be treated successfully by placing a D-J stent \[[@CR21]\],which can replace the patient's mental and physical trauma with easy acceptance, short hospitalization time, and fast recovery. Even if the UVF fails to heal, it can be used in first-stage treatment in full drainage to protect renal function and lay a good foundation for stage II surgery.

For some severe ureteric injuries, retrograde stenting is sometimes unsuccessful. Combining our practice with the literature review, we believe that the realignment retrograde/antegrade stenting approach is feasible by inserting the guide wire into the injury from the percutaneous nephroscope channel \[[@CR22]\] and using the ureteroscope to grasp the guide wire out from the urethra, then pass the D-J stent along the guide wire and over the injury.

In a minority of situations, in which a patient presents with a severe ureteral injury---completely lacerated or atretic---such that a guide wire cannot be passed in either in a retrograde or antegrade fashion, endoscopic realignment for treatment and "cut-to-the-light" technique should be employed \[[@CR6]\].

Compared with retrograde stenting, the extravasation of urine and washing fluid can be smoothly accomplished provided there is sufficient time and operating space for surgery. It would made stenting easier, more readily available, safer, and less invasive.

Therefore, it is appropriate for patients with a history of open pelvic and radical gynecologic surgery, multiple casualties, and those with severe fever, local inflammatory reaction, or severe shock.

Additional advantages of this method are as follows:It is easy to find both ends of ureteral injury and approach its focus along the nephrostomy channel by means of double ureteroscopic realignment, which increases the success rate of prograde or retrograde ureteric stenting, avoiding additional surgery, or ureteric reimplantation or placement of a percutaneous nephrolithotomy (PCN) tube.It ensures that the guide wire reaches the injury using direct vision and avoids exacerbating the ureter injury during adjustment of the guide wire's position and direction during the procedure.It is particularly appropriate for patients with failing retrograde ureteric stenting; patients who suffer from a severed ureter, severe injury, or ureter distortion; those who cannot tolerate long-term indwelling of a urinary catheter; and those with an advanced tumor.The flank-reclining, split-leg position provides sufficient operating space to perform a PCN and retrograde ureteroscopy simultaneously.

Although the endoscopic realignment was successfully used, some obvious disadvantages of the method are as follows: In some cases with normal or mild hydronephrosis, it is difficult to gain access to a nondilated renal collecting system because of urine leakage.The ureter is easy to collapse and block after pulling out the ureteral stent in patients who have long suffered from defects of ureteric avulsion or transection (usually \> 2 cm), serious stricture formation, repeated surgeries, or serious fibrosis of the ureteral surroundings. In addition, this procedure should be performed before the flexible ureteroscopy's light no longer penetrates the tissue between the ureteroscopes. However, more studies with longer, consecutive follow-ups and mass cases are necessary to predict prognosis in the future.

Conclusions {#Sec11}
===========

UVF is an uncommon iatrogenic complication of gynecologic surgery and difficult to diagnosis early. The incidence is more common in patients who have had radical hysterectomy. Minimally invasive methods using the D-J stent are safe and effective techniques for managing delayed UVF. We strongly recommend minimally invasive treatment of fistulae assisted with the ureteroscope to raise the cure rate, reduce the period of pain, and improve the survival rate.
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